| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/03/2005 | CN1649604A Separate type medical material |
| 08/03/2005 | CN1649601A Difructose anhydride-containing composition and use thereof |
| 08/03/2005 | CN1649595A Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 08/03/2005 | CN1649582A Amino-methyl substituted tetracycline compounds |
| 08/03/2005 | CN1649581A Substituted 3-amino-thieno(2, 3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 08/03/2005 | CN1649576A Methods and compositions for treatment of cancer pain |
| 08/03/2005 | CN1649574A Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies |
| 08/03/2005 | CN1649569A Controlled release dosage forms |
| 08/03/2005 | CN1649513A Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 08/03/2005 | CN1647810A Chinese medicinal capsule for treating ostealgia disease |
| 08/03/2005 | CN1647809A Shenjin pill for treating hyperplastic osteoarthritis and rheumatism and its preparing method |
| 08/03/2005 | CN1647808A Soft wound pill for treating protrusion of intervertebral disc and meniscus damage and its preparing method |
| 08/03/2005 | CN1213045C Tyrosine kinase inhibitors |
| 08/03/2005 | CN1213040C Serine protese inhibitors |
| 08/03/2005 | CN1213036C Novel amide derivatives |
| 08/03/2005 | CN1213028C Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl IV, processes for their preparation, and their use |
| 08/03/2005 | CN1213021C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl-3-substituted-alkyl, aryl or heteroarylamides) as matrix metallo protein inhibitors |
| 08/03/2005 | CN1213020C Phenylalaninol derivatives |
| 08/03/2005 | CN1212857C Osteodynia alleviating and wind dispelling liniment |
| 08/03/2005 | CN1212852C Medicine for curing cervical spondylopathy |
| 08/03/2005 | CN1212835C Hydroxamate-containing cysteine and serine protease inhibitors |
| 08/02/2005 | US6924305 Diazocine derivatives and their use as tryptase inhibitors |
| 08/02/2005 | US6924297 Naphathalene derivatives which bind to the EP4 receptor |
| 08/02/2005 | US6924292 Nitrogen compounds such as 2-(methylsulfinyl) N [3-(3,4,8,9-tetrahydro-6-methoxy-3,3,8,8-tetramethylfuro[2,3-h]isoquinolin-1-yl)phenyl]acetamide, used as phosphodiesterase inhibitors; antidiabetics; antiinflammatory agents |
| 08/02/2005 | US6924290 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders |
| 08/02/2005 | US6924288 Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 08/02/2005 | US6924281 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents |
| 08/02/2005 | US6924280 Dipeptide derivatives |
| 08/02/2005 | US6924276 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
| 08/02/2005 | US6924266 NTP-peptides and method for removal of tumors |
| 08/02/2005 | US6924100 Nucleotide sequences coding preferential polypeptide for use in the treatment and diagnosis of cardiovascular disorders and headaches |
| 08/02/2005 | US6923988 Solid carrier includes a hydrophililc surfactant and a drug |
| 08/02/2005 | CA2304821C Osteoblast-specific mitogens and drugs containing such compounds |
| 08/02/2005 | CA2243199C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 07/28/2005 | WO2005068624A1 Method of screening remedy for rheumatoid arthritis |
| 07/28/2005 | WO2005067975A1 Title: a sustained release captopril formulation having a supermolecular intercalation structure and the preparation process thereof |
| 07/28/2005 | WO2005067951A1 Botanical extract composition |
| 07/28/2005 | WO2005067942A1 Glycosaminoglycan peptides derived from connective tissues and use thereof in the prevention of arthritis and other degenerative medical conditions |
| 07/28/2005 | WO2005067920A1 Therapeutic drugs for arthritis |
| 07/28/2005 | WO2005034838A3 Protease inhibitors |
| 07/28/2005 | WO2005014650A3 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 07/28/2005 | WO2003072035A8 Compositions and methods for the treatment of immune related diseases |
| 07/28/2005 | US20050165232 Phenyl substituted imidaopyridines and phenyl substituted benzimidazoles |
| 07/28/2005 | US20050165113 (3S)-N-butyl-3-((2S)-2-(((4-fluorophenyl)sulfonyl)amino)-3-methylbutanoylamino)-5-methyl-2-oxohexanamide; calpain inhibition; Alzheimer's, osteoporosis, brain and eye disorders, ischemia |
| 07/28/2005 | US20050165106 Preferentially inhibit the inducible isoform of nitric oxide synthase |
| 07/28/2005 | US20050165103 for enhancing the endogenous production of interleukin-10 (IL-10) and suppressing the production of interleukin-2 in mammalian cells or tissues; inhibiting the proliferation of stimulated peripheral mononuclear cells |
| 07/28/2005 | US20050165087 Nf-kb inhibitors |
| 07/28/2005 | US20050165086 Aminothiophene inhibitors of NF- kappa B inhibitors for treatment of diseases such as cancer or aids |
| 07/28/2005 | US20050165080 Administering a selective imidazoline receptor agonist: moxonidine, rilmenidine, 1,4-diisopropyl-2-(4,5-dihydro-1H-imidazol-2-yl)-piperazine, 1-(4,5-dihydro-1H-imidazol-2-yl)-isoquinoline; treating osteoporosis and hypertension simultaneously; perimenopausal or postmenopausal female |
| 07/28/2005 | US20050165064 Novel thiol derivative, process for producing the same and use thereof |
| 07/28/2005 | US20050165063 Amine compounds and use thereof |
| 07/28/2005 | US20050165039 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 07/28/2005 | US20050165036 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050165011 6-[5-(6-methyl-pyridin-2-yl)-1H-[1,2,3]triazol-4-yl]-4H-benzo[1,4]oxazin-3-one, used as inhibitors of the transforming growth factor beta-signalling pathways, in particular, the phosphorylation of smad gene and proteins or activin-like kinase receptors; prophylaxis of kidney fibrosis |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164980 Endcapped block polymers including ethylene oxide-propylene oxide, glycolic acid-lactic acid, or ethylene oxide-lactic or glycolic acid; low viscosity allows easy injection; capable of room temperature distribution; extended analgesic effectiveness; nontoxic antiarthritic agents; tissue repair |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163863 use of arsenic for treating autoimmune diseases, in particular autoimmune lymphoproliferative syndrome |
| 07/28/2005 | US20050163728 A mixture of polypeptides, as calcium binding protein for reducing bone loss and reducing renal phosphate excretion; biodrug for treating bone disorders; injectable solution or dispersed in toothpaste or a mouthwash or gum patch |
| 07/28/2005 | DE10359384A1 Verwendung eines Extraktes von Aloysia triphylla als Matrixprotektor Use of an extract of Aloysia triphylla as a matrix protector |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557427A2 Hedgehog protein conjugate |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1557176A1 Treatment of bone metastases by means of PTH receptor agonists |
| 07/27/2005 | EP1557175A1 Remedy for bone metabolic diseases |
| 07/27/2005 | EP1557174A1 Composition containing eosinophil cationic protein |
| 07/27/2005 | EP1556488A2 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/27/2005 | EP1556410A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1556140A2 Novel compounds |
| 07/27/2005 | EP1556080A1 Use of convertase inhibitors in the treatment of fibrosis and scarring |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556057A2 Agents and methods for enhancing bone formation |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556049A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors |
| 07/27/2005 | EP1556041A1 A new crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid |
| 07/27/2005 | EP1556040A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2 |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1320295A4 Collagen/polysaccharide bilayer matrix |
| 07/27/2005 | EP1283823A4 Novel mmp-2/mmp-9 inhibitors |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1263444B1 Use of xanthine derivatives for preparing a medicine for preventing and treating osteoporosis |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP0990000B1 Connective tissue growth factor-3 |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646531A Thioxanthine derivatives as myeloperoxidase inhibitors |
| 07/27/2005 | CN1646524A Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |